AstraZeneca at ASN 2023: Anjay Rastogi in a Stimulating Conversation with PharmaShots

Shots:Anjay Rastogi, Professor, and Clinical Chief of Nephrology at UCLA, in an insightful conversation with PharmaShots, shares the highlights of AstraZeneca’s presentation at the American Society of NephrologyAt ASN 2023, AstraZeneca shares the analysis from the ZORA study, which is a global RWE program that describes the risk of progression to end-stage kidney…

BySaurabh ChaubeyFebruary 12, 2024

VIEWPOINTS

Eli Khankin Shares Update on the P-III IMAGINE Study Protocol Published in American Journal of Transplantation

Shots:Eli spoke about the P-III IMAGINE study protocol evaluating Clazakizumab along with 6 articles by several experts published in the American Journal of TransplantationEli then talked about Clazakizumab's potential mechanism of action currently under investigationThe interview shows how CSL Behring works to develop and deliver innovative therapies for people living with conditions in…

BySenior EditorAugust 31, 2023

TOP 20

Top 20 Immunology Companies Based on 2022 Immunology Segment Total Revenue

Shots:With the noble responsibility of ensuring a healthy society on their shoulders, biopharma companies focused on Immunology are diligently working to develop treatments, vaccines, antibodies, and drugsThe global Immunology market was valued at $97.93B in 2021 and is anticipated to reach $184.21B by 2029 with a CAGR of 8.5 percent. In 2022, AbbVie…

ByPrince GiriAugust 14, 2023

AstraZeneca at ASN 2023: Anjay Rastogi in a Stimulating Conversation with PharmaShots

Eli Khankin Shares Update on the P-III IMAGINE Study Protocol Published in American Journal of Transplantation

Top 20 Immunology Companies Based on 2022 Immunology Segment Total Revenue

Contact US

OUR INFORMATION

FOLLOW US